High-quality natural products for vital, healthy lifestyles since 1972
Research identifies 4080mcg daily as the therapeutic dose range for muscle hypertrophy, with 60mcg post-workout representing the most common starting point
This article will review the role of GLP-1 receptor agonists in the treatment of T2DM with a focus on the safe and appropriate use of GLP-1 analogue therapies in those with T2DM, and the instrumental role pharmacists have in ensuring that patients are adequately educated regarding these agents
Naunyn Schmiedebergs Arch Pharmacol (2020) 393:60314
Incretin-like drugs mimic these hormones, and while we do not have any head-to-head trials, you can see from the informative Figure below, summarizing best results of this family of drugs to date, moving from single agonist GLP-1 to double and then triple (GLP-1-GIP-GCG), there is incremental body weight loss